These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 30007563

  • 1. Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents.
    Xu Y, Jing D, Chen R, Rashid HU, Jiang J, Liu X, Wang L, Xie P.
    Bioorg Med Chem; 2018 Aug 07; 26(14):4136-4144. PubMed ID: 30007563
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. QSAR prediction, synthesis, anticancer evaluation, and mechanistic investigations of novel sophoridine derivatives as topoisomerase I inhibitors.
    Zhu L, Yu Y, Ma Y, Shi Y, Kowah JAH, Wang L, Yuan M, Liu X.
    Fitoterapia; 2024 Jun 07; 175():105921. PubMed ID: 38561052
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.
    Zhang C, Li S, Ji L, Liu S, Li Z, Li S, Meng X.
    Bioorg Med Chem Lett; 2015 Oct 15; 25(20):4693-6. PubMed ID: 26384290
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacophore-based, rationale design, and efficient synthesis of novel tetrahydrobenzo[b]thiophene candidates as potential dual Topo I/II inhibitors and DNA intercalators.
    Nofal HR, Al-Karmalawy AA, Elmaaty AA, Ismail MF, Ali AK, Abbass EM.
    Arch Pharm (Weinheim); 2024 Sep 15; 357(9):e2400217. PubMed ID: 38864845
    [Abstract] [Full Text] [Related]

  • 10. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
    Huang WY, Zhang XR, Lyu L, Wang SQ, Zhang XT.
    Bioorg Chem; 2020 Jun 15; 99():103814. PubMed ID: 32278208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel N-substituted sophoridinol derivatives as anticancer agents.
    Bi CW, Zhang CX, Li YH, Tang S, Deng HB, Zhao WL, Wang Z, Shao RG, Song DQ.
    Eur J Med Chem; 2014 Jun 23; 81():95-105. PubMed ID: 24826818
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular Design, Synthesis and Docking Study of Alkyl and Benzyl Derivatives of Robustic Acid as Topoisomerase I Inhibitors.
    Chen R, Huang J, Jaiswal Y, Wei J, Huo L, Xia X, Zhong J, Williams L, Huang M, Liang Y.
    Chem Biodivers; 2020 Mar 23; 17(3):e1900556. PubMed ID: 31943759
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and biological evaluation of lapachol derivatives possessing indole scaffolds as topoisomerase I inhibitors.
    Zhang C, Qu Y, Niu B.
    Bioorg Med Chem; 2016 Nov 15; 24(22):5781-5786. PubMed ID: 27667553
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis and biological evaluation of matrine derivatives as potential anticancer agents.
    Li Z, Luo M, Cai B, Wu L, Huang M, Haroon-Ur-Rashid, Jiang J, Wang L.
    Bioorg Med Chem Lett; 2018 Feb 15; 28(4):677-683. PubMed ID: 29395978
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
    Majumdar P, Bathula C, Basu SM, Das SK, Agarwal R, Hati S, Singh A, Sen S, Das BB.
    Eur J Med Chem; 2015 Sep 18; 102():540-51. PubMed ID: 26312433
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT, Woo H, Jeong HM, Khadka DB, Yang SH, Zhao C, Jin Y, Lee ES, Youl Lee K, Kwon Y, Cho WJ.
    Eur J Med Chem; 2014 Jul 23; 82():181-94. PubMed ID: 24904965
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison.
    Acar Çevik U, Sağlık BN, Osmaniye D, Levent S, Kaya Çavuşoğlu B, Karaduman AB, Atlıd Ö, Atlı Eklioğlu Ö, Kaplancıklı ZA.
    J Enzyme Inhib Med Chem; 2020 Dec 23; 35(1):1657-1673. PubMed ID: 32811204
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors.
    Liu W, Zhu L, Guo W, Zhuang C, Zhang Y, Sheng C, Cheng P, Yao J, Wang W, Dong G, Wang S, Miao Z, Zhang W.
    Eur J Med Chem; 2011 Jun 23; 46(6):2408-14. PubMed ID: 21463912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.